Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
06 May 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/250-more-nih-workers-laid-including-cuts-national-cancer-institute
13 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/13/3042134/37149/en/PDS-Biotech-Announces-FDA-Clearance-of-IND-Application-for-Combination-of-Versamune-MUC1-and-PDS01ADC-to-Treat-Metastatic-Colorectal-Cancer.html
12 Nov 2024
// BUSINESSWIRE
29 Oct 2024
// BUSINESSWIRE
14 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/us-fda-issues-study-may-proceed-letter-for-the-pilot-study-of-pidnarulex-pharmacodynamics-in-patients-with-advanced-solid-tumors-sponsored-by-the-us-national-cancer-institute-302274665.html
17 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/scitech-development-inc-announces-receipt-of-drug-supply-from-the-national-cancer-institute-nci-302249654.html
ABOUT THIS PAGE
National Cancer Institute is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Bevacizumab+Rituximab bulk offered by National Cancer Institute
Find a price of 2-CYANO-3, 12-DIOXOOLEANA-1, 9(11)-DIEN-28-OIC ACID (CDDO) bulk offered by National Cancer Institute
Find a price of HUMANIZED MIK-BETA-1 MONOCLONAL ANTIBODY bulk offered by National Cancer Institute